Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington’s Disease: A Systematic Review
Abstract Background: Studies focusing on the treatment of neuropsychiatric symptoms (NPS) in Huntington’s disease (HD) are scarce and show a wide variation in design, outcome measures and methodological quality. The effectiveness of pharmacological treatment of NPS in HD has not been systematically reviewed so far. Objective: To provide an overview of the available literature on the effectiveness of pharmacological treatment of NPS in HD. Methods: PubMed and the Cochrane library were systematically searched for studies assessing the effects of pharmacotherapy
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in